You are required to be logged in to access the full website
Click here if you have forgotten your username or password
6 March 2026 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its TECVAYLI (teclistamab-cqyv) plus DARZALEX FASPRO (daratum...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe